Predictive Value of Minimal Residual Disease for Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European Mantle Cell Lymphoma Elderly Trial - Hoster, E; Delfau-Larue, MH; Macintyre, E (J Clin Oncol, 2024)
et al.